Anti-proliferative and cytotoxic activity of rosuvastatin against melanoma cells
Introduction : Statins are considered potential candidate agents for melanoma chemoprevention. Statin-induced mevalonate pathway inhibition leads to reduction of cholesterol synthesis and also to decreased cellular levels of non-steroidal isoprenoids, geranylgeranyl pyrophosphate and farnesyl pyroph...
Main Authors: | Malgorzata Maj, Rafal Czajkowski, Barbara Zegarska, Bogna Kowaliszyn, Marta Pokrywczynska, Tomasz Drewa |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-08-01
|
Series: | Advances in Dermatology and Allergology |
Subjects: | |
Online Access: | https://www.termedia.pl/Anti-proliferative-and-cytotoxic-activity-of-rosuvastatin-against-melanoma-cells,7,28100,1,1.html |
Similar Items
-
Hepatotoxicity Associated with a Short Course of Rosuvastatin
by: Na Kyoung Hwang, et al.
Published: (2015-01-01) -
Review of selected herbal phytoconstituents for potential melanoma treatment
by: Bhaskar Kallappa Kurangi, et al.
Published: (2018-01-01) -
Analysis of genetic aspects of therapy with Rosuvastatin
by: Samat Kozhakhmetov, et al.
Published: (2016-06-01) -
A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01) -
Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity
by: Tarek A. Ahmed
Published: (2020-02-01)